Merus
At Merus, we are clinically advancing leading-edge, targeted treatments to address the unmet needs of patients with various types of cancer.
Basic Information
- Category: Antibody Therapeutics
- Founded: 2003
- Headquarters: Utrecht, Netherlands
- Website: merus.nl
Documented Facts
- Phone: 0031850162500 (No linked source recorded for this statement.)
- Email: enquiries@merus.nl (No linked source recorded for this statement.)
Evidence and Sources
- Merus — Official Site (official)
- Merus on linkedin (social)
Citation Guidance
Explore Antibody Therapeutics profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Merus.
- Canonical profile: https://brandsource.ai/brands/merus
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/merus/json-ld
- Citation profile API: https://brandsource.ai/api/brands/merus/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (84/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-28T04:26:07.295Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
At Merus, we are clinically advancing leading-edge, targeted treatments to address the unmet needs of patients with various types of cancer.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.